Pedro Henrique Bastos e Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pedro Henrique Bastos e Silva has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Giliane de Souza Trindade
Laboratório de Vírus, Instituto de Ciências Biológicas, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil
4 shared publications - Ana Gabriella Stoffella-Dutra
Laboratório de Vírus, Instituto de Ciências Biológicas, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil
3 shared publications - Erna Geessien Kroon
Laboratório de Vírus, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil
3 shared publications - Felipe Campos de Melo Iani
Laboratório Central de Saúde Pública, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil
3 shared publications - Iago José da Silva Domingos
Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Antonio Carlos, 6627, Belo Horizonte 31270-901, Brazil
3 shared publications - Iara Monteiro de Almeida
Laboratório de Vírus, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil
2 shared publications
Latest Publications
- Open Access
Evidence of Multispecies Zoonotic Poxvirus Circulation in the Brazilian Amazon from Molecular, Serologic, and Genomic Investigations in 2021–2024
Zoonotic poxviruses are not well characterized in the Amazon region. We investigated poxvirus among domestic animals in Pará State from 2021–2024, in smallholder farming systems. We collected 440 specimens from 412 animals across rural municipalities and tested them using orthopoxvirus and parapoxvirus specific qPCR assays, plaque reduction neutralization tests, virus isolation, and whole-genome sequencing. Orthopoxvirus-neutralizing antibodies were detected in 12.2% of serum samples, predominantly in buffaloes. Vaccinia virus DNA was detected in five cattle scab specimens from Bom Jesus do Tocantins, and infectious virus was isolated from one specimen. Parapoxvirus DNA was detected in 19 specimens, including orf virus and pseudocowpox virus, and one goat specimen was positive for both viruses. Complete genome sequences were obtained for vaccinia virus, orf virus, and pseudocowpox virus, representing the first publicly available complete genomes of orf virus and pseudocowpox virus from Brazil and the first vaccinia virus genome from the Brazilian Amazon. These findings demonstrate contemporary multispecies circulation of zoonotic poxviruses in the Brazilian Amazon and highlight the need for integrated One Health surveillance.
Open AccessEvidence of Multispecies Zoonotic Poxvirus Circulation in the Brazilian Amazon from Molecular, Serologic, and Genomic Investigations in 2021–2024
Zoonotic poxviruses are not well characterized in the Amazon region. We investigated poxvirus among domestic animals in Pará State from 2021–2024, in smallholder farming systems. We collected 440 specimens from 412 animals across rural municipalities and tested them using orthopoxvirus and parapoxvirus specific qPCR assays, plaque reduction neutralization tests, virus isolation, and whole-genome sequencing. Orthopoxvirus-neutralizing antibodies were detected in 12.2% of serum samples, predominantly in buffaloes. Vaccinia virus DNA was detected in five cattle scab specimens from Bom Jesus do Tocantins, and infectious virus was isolated from one specimen. Parapoxvirus DNA was detected in 19 specimens, including orf virus and pseudocowpox virus, and one goat specimen was positive for both viruses. Complete genome sequences were obtained for vaccinia virus, orf virus, and pseudocowpox virus, representing the first publicly available complete genomes of orf virus and pseudocowpox virus from Brazil and the first vaccinia virus genome from the Brazilian Amazon. These findings demonstrate contemporary multispecies circulation of zoonotic poxviruses in the Brazilian Amazon and highlight the need for integrated One Health surveillance.
- Open Access
Vaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil
Co-infections of Orthopoxviruses (OPVs), such as vaccinia virus (VACV) and monkeypox virus (MPXV), and the human immunodeficiency virus (HIV) can be associated with severe outcomes. Serro’s dairy region, located in Minas Gerais, southeastern Brazil, is an endemic area for VACV, where zoonotic outbreaks affect rural communities. This epidemiological context is especially relevant for at-risk populations, such as people living with HIV (PLHIV). This study aimed to assess the presence of neutralizing antibodies (NAbs) against OPV in PLHIV in this endemic setting. Serum samples were collected from 177 PLHIV in treatment at the specialized service between December 2021 and August 2022. VACV and MPXV NAbs were measured using the plaque reduction neutralization test (PRNT) and VACV-infected cells. The overall occurrence of OPV NAbs was 27.7%. NAbs were higher in individuals born before 1980 (53.3%) than those born after 1980 (1.1%). Among anti-VACV-seropositive individuals, 40.8% also had MPXV NAbs, suggesting cross-immunity. These findings indicate the circulation of VACV in PLHIV and highlight the increased susceptibility to OPV infections among individuals born after the cessation of smallpox vaccination. The results reinforce the importance of continued surveillance of OPV, especially in endemic regions and vulnerable populations.
Open AccessVaccinia and Monkeypox Virus-Neutralizing Antibodies in People Living with HIV: A Serological Study in a Orthopoxvirus-Endemic, Low-Income Region in Brazil
Co-infections of Orthopoxviruses (OPVs), such as vaccinia virus (VACV) and monkeypox virus (MPXV), and the human immunodeficiency virus (HIV) can be associated with severe outcomes. Serro’s dairy region, located in Minas Gerais, southeastern Brazil, is an endemic area for VACV, where zoonotic outbreaks affect rural communities. This epidemiological context is especially relevant for at-risk populations, such as people living with HIV (PLHIV). This study aimed to assess the presence of neutralizing antibodies (NAbs) against OPV in PLHIV in this endemic setting. Serum samples were collected from 177 PLHIV in treatment at the specialized service between December 2021 and August 2022. VACV and MPXV NAbs were measured using the plaque reduction neutralization test (PRNT) and VACV-infected cells. The overall occurrence of OPV NAbs was 27.7%. NAbs were higher in individuals born before 1980 (53.3%) than those born after 1980 (1.1%). Among anti-VACV-seropositive individuals, 40.8% also had MPXV NAbs, suggesting cross-immunity. These findings indicate the circulation of VACV in PLHIV and highlight the increased susceptibility to OPV infections among individuals born after the cessation of smallpox vaccination. The results reinforce the importance of continued surveillance of OPV, especially in endemic regions and vulnerable populations.
- Open Access
Geographic Distribution of Vaccinia Virus, Diagnosis and Demographic Aspects of Affected Populations, Minas Gerais, Brazil, 2000–2023
Since its first report in Brazil in 1999, outbreaks of exanthematous diseases caused by vaccinia virus (VACV) have been a recurring concern, particularly impacting rural regions. Minas Gerais (MG) State, Brazil, has emerged as the epicenter of bovine vaccinia (BV) outbreaks. This study presents a comprehensive overview of VACV circulation in MG State over the past two decades, examining the occurrence and distribution of poxvirus cases and outbreaks and the demographic characteristics of affected populations. Analysis of secondary databases from 2000 to 2023 revealed VACV circulation in at least 149 municipalities, particularly expanding in dairy regions. The study underscores BV as an occupational disease, predominantly affecting rural men involved in dairy cattle activities. Laboratory findings indicate high levels of anti-OPXV antibodies in most individuals, with some showing acute infections confirmed by qPCR testing. This analysis informs public health policies, emphasizing the need for enhanced surveillance of and preventive measures for dairy farming communities.
Open AccessGeographic Distribution of Vaccinia Virus, Diagnosis and Demographic Aspects of Affected Populations, Minas Gerais, Brazil, 2000–2023
Since its first report in Brazil in 1999, outbreaks of exanthematous diseases caused by vaccinia virus (VACV) have been a recurring concern, particularly impacting rural regions. Minas Gerais (MG) State, Brazil, has emerged as the epicenter of bovine vaccinia (BV) outbreaks. This study presents a comprehensive overview of VACV circulation in MG State over the past two decades, examining the occurrence and distribution of poxvirus cases and outbreaks and the demographic characteristics of affected populations. Analysis of secondary databases from 2000 to 2023 revealed VACV circulation in at least 149 municipalities, particularly expanding in dairy regions. The study underscores BV as an occupational disease, predominantly affecting rural men involved in dairy cattle activities. Laboratory findings indicate high levels of anti-OPXV antibodies in most individuals, with some showing acute infections confirmed by qPCR testing. This analysis informs public health policies, emphasizing the need for enhanced surveillance of and preventive measures for dairy farming communities.
- Open Access
- 23 September 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (6)
Phylogeny-aware linear B-cell epitope predictor detects targets associated with immune response to orthopoxviruses
We introduce a phylogeny-aware framework for predicting linear B-cell epitope (LBCE)-containing regions within proteins. Our approach leverages evolutionary information by using a taxonomic scaffold to build models trained on hierarchically structured data. The resulting models present performance equivalent or superior to generalist methods, despite using simpler features and a fraction of the data volume required by current state-of-the-art predictors. This allows the utilization of available data for major pathogen lineages to facilitate the prediction of LBCEs for emerging infectious agents. We demonstrate the efficacy of our approach by predicting new LBCEs in the monkeypox (MPXV) and vaccinia viruses. Experimental validation of selected targets using sera from infected patients confirms the presence of LBCEs, including candidates for the differential serodiagnosis of recent MPXV infections. These results point to the use of phylogeny-aware predictors as a useful strategy to facilitate the targeted development of immunodiagnostic tools.
- 23 September 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (6)
Open AccessPhylogeny-aware linear B-cell epitope predictor detects targets associated with immune response to orthopoxviruses
We introduce a phylogeny-aware framework for predicting linear B-cell epitope (LBCE)-containing regions within proteins. Our approach leverages evolutionary information by using a taxonomic scaffold to build models trained on hierarchically structured data. The resulting models present performance equivalent or superior to generalist methods, despite using simpler features and a fraction of the data volume required by current state-of-the-art predictors. This allows the utilization of available data for major pathogen lineages to facilitate the prediction of LBCEs for emerging infectious agents. We demonstrate the efficacy of our approach by predicting new LBCEs in the monkeypox (MPXV) and vaccinia viruses. Experimental validation of selected targets using sera from infected patients confirms the presence of LBCEs, including candidates for the differential serodiagnosis of recent MPXV infections. These results point to the use of phylogeny-aware predictors as a useful strategy to facilitate the targeted development of immunodiagnostic tools.